Summary - NVS - NYSE - Weiss Ratings

B

Novartis AG NVS

$126.55 $0.080.06% NYSE

Recommendation

Prev Close

Volume

Avg Vol (90D)

Market Cap

Dividend & Yield

52-Week Range

$96.06 - $128.03

P/E (TTM)

EPS (TTM)

My Lists My Alerts

Access our Premium Ratings

Get Access

Rating

Reward

Risk

Rating Factors

Growth Index

Efficiency Index

Solvency Index

Total Return Index

Volatility Index

Dividend Index

Headlines

3 Top Big Pharma Stocks Investing Over $100 Billion in the U.S.

4/28/2025 - MarketBeat

11 Best Pharma Stocks to Invest in for the Long Term

8/31/2025 - Insider Monkey

Novartis (NVS) Strengthens Outlook With Ianalumab Trial Success and Leqvio Expansion

8/31/2025 - Insider Monkey

Novartis (NVS) Reveals Promising V-DIFFERENCE Study Results

8/30/2025 - GuruFocus

Novartis' Leqvio shows statistically significant LDL-C goal achievement in study

8/30/2025 - TipRanks Financial Blog

Novartis' Leqvio shows statistically significant LDL-C goal achievement in study

8/30/2025 - The Fly

Novartis AG $NVS Shares Sold by Gabelli Funds LLC

8/30/2025 - MarketBeat

Kestra Advisory Services LLC Lowers Stock Position in Novartis AG $NVS

8/30/2025 - MarketBeat

Can CRSP's In Vivo Pipeline Aid Long-Term Growth Beyond Casgevy?

8/29/2025 - Zacks Investment Research

Earnest Partners LLC Grows Position in Novartis AG $NVS

8/29/2025 - MarketBeat

Incyte (INCY) Up 9.4% Since Last Earnings Report: Can It Continue?

8/28/2025 - Zacks Investment Research

Are You a Value Investor? This 1 Stock Could Be the Perfect Pick

8/28/2025 - Zacks Investment Research

CRSP vs. BEAM: Which Gene Editing Stock Holds More Potential Right Now?

8/28/2025 - Zacks Investment Research

BioArctic AB Sees Growth with Leqembi and Novartis Partnership

8/28/2025 - TipRanks Financial Blog

Exelixis and Novartis: Key Updates from the Pan Tumor Rollover Study

8/27/2025 - TipRanks Financial Blog

NHS to lose out on new drugs, pharma firm warns

8/27/2025 - BBC News Business World Edition

Apexium Financial LP Buys New Shares in Novartis AG $NVS

8/27/2025 - MarketBeat

11 Best Annual Dividend Stocks to Buy According to Hedge Funds

8/27/2025 - Insider Monkey

What Legend Biotech (LEGN)'s CFO Appointment Means for Shareholders

8/27/2025 - Simply Wall St

BioArctic (BIOA B) Partners with Novartis for Neurodegenerative Treatment

8/26/2025 - GuruFocus

Novartis and BioArctic sign collaboration and license deal

8/26/2025 - Seeking Alpha - Healthcare

Novartis and BioArctic sign collaboration and license deal

8/26/2025 - SeekingAlpha.com: All News

Can Label Expansion of Cabometyx Fuel Further Growth for EXEL?

8/26/2025 - Zacks Investment Research

Novartis (NVS) Partners with BioArctic for Neurodegenerative Drug Development

8/26/2025 - GuruFocus

3 Momentum Stocks That Could Soar Post-Market Volatility

4/21/2025 - MarketBeat

Income Statement

Total Revenue (TTM)

EBITDA (TTM)

EBIT (TTM)

Net Income (TTM)

Balance Sheet

Total Assets (Q)

Total Debt (Q)

Total Liabilities (Q)

Book Value Per Share (Q)

Cash Flow

Cash from Operations (TTM)

Cash from Investing (TTM)

Cash from Financing (TTM)

Net Change in Cash (TTM)

Filings

Filing Date

Thursday, July 17, 2025

Period Date

Monday, June 30, 2025

Next Filing

Week of Oct 27 and 31 (est)

Price History

Loading...

Beta

7-Day Total Return

30-Day Total Return

60-Day Total Return

90-Day Total Return

Year to Date Total Return

1-Year Total Return

2-Year Total Return

3-Year Total Return

5-Year Total Return

52-week Low

Dec 20, 2024 - $96.06

52-week High

Aug 22, 2025 - $128.03

Valuation

Market Cap

$244.15B - Mega Cap

Enterprise Value

Price/Sales (TTM)

Price/Book (Q)

Dividends and Shares

Shares Outstanding

Dividend Per Share (Most Recent)

Dividend Per Share (TTM)

Corporate Info

Website

www.novartis.com

Phone Number

41 61 324 11 11

Address

Lichtstrasse 35
Basel, 4056

Country

Year Founded

Business Description

Sector

--

Industry

--

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an... more